First Manhattan’s Exact Sciences EXAS Stock Holding History

First Manhattan’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,990	Closed	-$304K	–	766
2025 Q4	$304K	Sell	2,990 -805	-21%	-$64.6K	﹤0.01%	643
2025 Q3	$208K	Buy	+3,795	New	+$190K	﹤0.01%	679
2023 Q2	–	Sell	-90	Closed	-$6.1K	–	1465
2023 Q1	$6.1K	Sell	90 -52	-37%	-$3.34K	﹤0.01%	1267
2022 Q4	$7.03K	Hold	142	–	–	﹤0.01%	1327
2022 Q3	$4K	Hold	142	–	–	﹤0.01%	1337
2022 Q2	$5K	Hold	142	–	–	﹤0.01%	1330
2022 Q1	$9K	Sell	142 -32	-18%	-$2.34K	﹤0.01%	1287
2021 Q4	$13K	Buy	174 +52	+43%	+$4.59K	﹤0.01%	1237
2021 Q3	$11K	Buy	122 +32	+36%	+$3.38K	﹤0.01%	1262
2021 Q2	$11K	Hold	90	–	–	﹤0.01%	1261
2021 Q1	$11K	Hold	90	–	–	﹤0.01%	1217
2020 Q4	$11K	Hold	90	–	–	﹤0.01%	1131
2020 Q3	$9K	Hold	90	–	–	﹤0.01%	1133
2020 Q2	$7K	Hold	90	–	–	﹤0.01%	1205
2020 Q1	$5K	Hold	90	–	–	﹤0.01%	1230
2019 Q4	$8K	Buy	+90	New	+$7.91K	﹤0.01%	1168

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

First Manhattan's EXAS Position: Q1 2026 in Review

First Manhattan sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,990 shares — an estimated $304K sold.

First Manhattan first reported a position in EXAS in Q4 2019 and held it in 16 quarters. The position peaked at $304K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

First Manhattan reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
First Manhattan sold 2,990 Exact Sciences shares in Q1 2026, an estimated $304K.
First Manhattan first reported a position in Exact Sciences in Q4 2019 and held it in 16 quarters.
First Manhattan's Exact Sciences position peaked at $304K in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.